@TomSoule74 Profile picture

Thomas Soule

@TomSoule74

Nothing to See Here, Gone (Mostly) Quiet. Just Lurking until the Inevitable Implosion.

Pinned

More hypocritical nonsense from @MattNachtrab This scumbag has led a herd of anonymous and odious trolls to harass and threaten $SAVA critics for years. You are not fooling anyone, Matt. Piss off.

Tweet Image 1

Thomas Soule Reposted

No tolerance for death threats. Maggie/Jenny/John/Jane set the $SAVA stage daily for 3 YR to drive vindictive hate. Then @mattnachtrab aware of threats pulled the online trigger (albeit at the wrong person). I’m in CA, you morons. Not Stacy. @FBI and authorities contacted

Tweet Image 1

Thomas Soule Reposted

Oops. $SAVA promoter @mattnachtrab just owned by a former SEC official. x.com/Marc_Fagel/sta…

Tweet Image 1

False. The SEC sued them for fraud (specifically, for violating Section 17 of the Securities Act, which prohibits fraud in the sale of securities). Speaking here as a former SEC senior official who knows the definition of securities fraud.



Thomas Soule Reposted

The saddest part of this whole $SAVA debacle is that a bunch of lovely people are going to lose it all soon and no one even tried to warn them.


Thomas Soule Reposted

$SAVA new CCO has been an unemployed “consultant” for six years while running her online e-beauty hair care platform. Story writes itself.

Tweet Image 1

Thomas Soule Reposted

Congrats to @MicrobiomDigest, PubPeer, and the other winners of the Einstein Foundation Award for Promoting Quality in Research 2024! h/t @RetractionWatch award.einsteinfoundation.de/award-winners-…


Somebody seems nervous...

$SAVA promoter @MattNachtrab paid a 3rd party to produce a “testimonial” vid of patient Manny Tzagournis in an open label study 🔻w/out an AD diagnosis? 🔻omitting Matt’s $72M investment 🔻daughter “Dr. E” went to stock promoter Joe Springer 1st Meanwhile, another coincidence?

Tweet Image 1
Tweet Image 2
Tweet Image 3


Thomas Soule Reposted

$SAVA promoter @MattNachtrab paid a 3rd party to produce a “testimonial” vid of patient Manny Tzagournis in an open label study 🔻w/out an AD diagnosis? 🔻omitting Matt’s $72M investment 🔻daughter “Dr. E” went to stock promoter Joe Springer 1st Meanwhile, another coincidence?

Tweet Image 1
Tweet Image 2
Tweet Image 3

Good news for people who like bad news for $SAVA:

Magistrate recommends certifying the $SAVA class period (over double in size from original) to include the period 🔻from the Sept 2020 PR (Wang’s magic re-do) 🔻to the October 2023 bombshell CUNY report and FDA inspection of Dr. Wang.

Tweet Image 1


Thomas Soule Reposted

BREAKING: Cassava Sciences $SAVA does NOT dispute material misrepresentions or scienter in connection with simufilam and investor losses in TX court. #Alzheimers storage.courtlistener.com/recap/gov.usco…

Tweet Image 1

Thomas Soule Reposted

Magistrate recommends certifying the $SAVA class period (over double in size from original) to include the period 🔻from the Sept 2020 PR (Wang’s magic re-do) 🔻to the October 2023 bombshell CUNY report and FDA inspection of Dr. Wang.

Tweet Image 1

Thomas Soule Reposted

Ladies and gentlemen, I present Matt Nachtrab, the pied piper of $SAVA, who clearly doesn’t understand biotech - at all. This is gibberish.

Tweet Image 1
Tweet Image 2

Thomas Soule Reposted

These $SAVA “testimonials” to online stockholders (who does that??) are from the dubious P2 study - whose results the company said are no longer reliable - and lengthy open label (almost meaningless, except for safety).


Thomas Soule Reposted

Great to know that measles mumps and rubella will have a strong ally at HHS!


It is a testament to @MattNachtrab and his poor reading comprehension that he thinks RFK Jr. is going to save $SAVA. He doesn’t like pharma, you dipshit. Push-ups and sunshine are better than simufilam, you hapless half-wit.

Tweet Image 1

Thomas Soule Reposted

Witness the fundamental dishonesty of $SAVA supporters. I have published numerous stories with detailed analysis of Cassava’s studies that explain clearly why simufilam is inert and will fail its ph3 studies. Martin Shkreli has done likewise, as have others. Ignore us all,…

$SAVA The content of the claims made by the usual bashers like Feuerstein, LogarithmicDis, more recently Martin S. and others are becoming laughable. They claim there's no way simufilam will achieve its endpoints or be statistically significant (stat sig), but don't…



Thomas Soule Reposted

The whole $SAVA complaint is worth reading, but the scientific community should be especially concerned about this: @MicrobiomDigest @Thatsregrettab1 @mumumouse2 @schrag_matthew @cpiller @RetractionWatch

Tweet Image 1
Tweet Image 2

United States Trends
Loading...

Something went wrong.


Something went wrong.